SABPA

“Challenges to the 21st Century Medicine”

San Diego Bio-Pharma Conference 2006

June 10th, 2006, Price Center, UCSD

	(Agenda in PDF format for printing)
	(More presentations slides will be available soon)
8:00 am - 5:00 pm	Exhibition
8:00 am - 9:00 am	Continental Breakfast & Registration
9:00 am - 9:15 am	Welcome Xiangming Fang, (Slides)Program Co-Chair, Chair of Science & Technology Committee, SABPA,Vice President of R&D, GenWay Biotech, Inc. Yun He, (Slides)Program Co-Chair, President, SABPA, Associate Director, Medicinal Chemistry, Genomics Institute of Novartis Research Foundation
9:15 am - 9:40 am	Keynote Speech Perspectives of Biotechnology: U.S.A. and China (Abstract)(Slides) Shu Chien, Professor of Bioengineering and Medicine, UCSD
9:40 am - 11:20 am	Session 1: Metabolic and Infectious Diseases
	Rapid Structure-based Discovery of Novel Diabetes Drug Candidates: From Gene to Phase III in 45 Months (Abstract)(Slides) Stephen Kaldor, President and Chief Scientific Officer, Takeda San Diego, Inc.
	5HT2C Agonists in Obesity Drug Discovery and Development: Success and Challenge (Abstract)(Slides) Paul Maffuid, Vice President, Pharmaceutical Development, Arena Pharmaceuticals, Inc.
	CCR5 antagonists for HIV - Discovery of Maraviroc (Abstract)(Slides) Martin Edwards, Vice President, Pfizer Global Research & Development
	Chronic Viral Hepatitis (Abstract)(Slides) Devron R. Averett, Chief Scientific Officer, Anadys Pharmaceuticals, Inc.
11:20 pm - 12:30 pm	Luncheon
12:30 pm - 12:45 pm	Annual Symposium Award: TBA
12:45 pm - 2:25 pm	Session 2: Emerging Therapeutic Strategies and Regulatory Approval
	Developing Novel Therapeutics for the Impending Influenza Pandemics (Abstract) Fang Fang, Chief Scientific Officer & Chief Medical Officer, NexBio, Inc.
	Novel Cancer Therapeutics and Implications for Patient Management (Abstract)(Slides) Jon Holmlund, Chief Medical Officer, Vice President, Development, Ascenta Therapeutics, Inc.
	Identification of Novel Therapeutic Targets for Obesity/diabetes (Abstract)(Slides) Gen-Sheng Feng, Professor, Burnham Institute for Medical Research
	The Critical Path to New Medical Products Alice Wei , Vice-President, Regulatory Affairs and Quality, Favrille, Inc.
2:25 pm - 2:45 pm	Coffee Break
2:45 pm - 4:30 pm	Panel Discussion: Innovative Business Strategies Towards Pharmaceutical R&D (Abstract) Modulator: Alan Paau, (Slides)Assistant Vice Chancellor, UCSD Co- Modulator: John Oyler, (Slides) Chief Executive Officer, BioDuro, Inc.
	• How to improve the efficiency and reduce the cost for pharmaceutical R&D? • How new discoveries and technologies will impact the future pharmaceutical R&D? • How to find capital to start and sustain your business, both in the US and China ? And more. Paul Grayson, (Slides)Managing Director, Sanderling Ventures VI, L.P. John Gu, Chief Executive Officer, CytoPharm, Inc. Ming Guo, Vice President, Pharmaceutical Sciences & Manufacturing, Ascenta Therapeutics, Inc. James M. Schaeffer,(Slides) Executive Director, Licensing and External Research, Merck & Co. Inc. Mang Yu, President & Chief Executive Officer, NexBio Inc.
4:30 pm - 5:00 pm	Reception and Networking
5:00 pm	Closing